Home › Liver Cancer (Hepatocellular Carcinoma) › Texas › Dallas
Liver Cancer (Hepatocellular Carcinoma) clinical trials in Dallas, TX
19 studies for Liver Cancer (Hepatocellular Carcinoma) are looking for participants at sites in and around Dallas (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
RecruitingPhase 1
- Exelixis Clinical Site #89, Dallas
National Liver Cancer Screening Trial
RecruitingPhase 4
- UT Southwestern Medical Center and Parkland Hospital, Dallas
GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC
RecruitingPhase 1/2
- University of Texas Southwestern, Harold C. Simmons Comprehensive Cancer Center, Dallas
THIO and Cadonilimab in Resectable Hepatocellular Carcinoma
RecruitingEarly phase 1
- University of Texas Southwestern Medical Center, Dallas
Adaptive Dosing of Immune Checkpoint Inhibitors for Hepatocellular Carcinoma
RecruitingPhase 2
- University of Texas Southwestern Medical Center, Dallas
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
RecruitingPhase 1/2
- Texas Oncology, P.A., Dallas
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
RecruitingPhase 2
- Baylor Scott & White Research Institute, Dallas
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
RecruitingPhase 1
- University of Texas Southwestern Medical Center - Simmons Cancer Center, Dallas
- UT Southwestern Medical Center - Redbird, Dallas
- Univ. of TX Southwestern Medical Center - Zale Lipshy University Hospital, Dallas
- and 2 more
CEUS vs. AMRI for HCC Detection in Patients With Indeterminate Liver Nodules
Recruiting
- University of Texas Southwestern Medical Center, Dallas
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
RecruitingPhase 1
- Clinical Trial Site, Dallas
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
Recruiting
- VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX, Dallas
A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma
RecruitingPhase 1/2
- Harold C. Simmons Comprehensive Cancer Center, Dallas
Evaluation of Resection Techniques for Pancreatic Tumors
RecruitingObservational study
- Methodist Dallas Medical Center, Dallas
Ligufalimab and Cadonilimab in Advanced Liver Cancers
RecruitingPhase 2
- University of Texas Southwestern Medical Center, Dallas
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
RecruitingPhase 4
- UT Southwestern Medical Center, Dallas
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
RecruitingPhase 1/2
- Research Site 120, Dallas
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Dallas
EGCG for Hepatocellular Carcinoma Chemoprevention
RecruitingPhase 2
- UT Southwestern, Dallas
Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis
RecruitingPhase 3
- Site 881, Dallas
Liver Cancer (Hepatocellular Carcinoma) trials in other cities
- Houston, TX31 studies
- New York City, NY24 studies
- Los Angeles, CA19 studies
- Boston, MA18 studies
- Cleveland, OH18 studies
- Philadelphia, PA16 studies
- Chicago, IL16 studies
- Pittsburgh, PA15 studies
- San Francisco, CA14 studies
- Orange, CA14 studies
- Jacksonville, FL14 studies
- San Antonio, TX13 studies
Other studies in Dallas
- Breast Cancer55 studies
- Non-Small Cell Lung Cancer52 studies
- Metastatic Cancer42 studies
- Heart Failure42 studies
- Cancer (all types)37 studies
- Prostate Cancer36 studies
- Colorectal Cancer33 studies
- Obesity30 studies
- Ovarian Cancer28 studies
- Lung Cancer27 studies
- Bladder Cancer27 studies
- Endometrial Cancer24 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.